Physiological homeostasis is traditionally viewed as an individual process optimized through evolution to minimize the ...

"AI will skillfully domesticate humans." This vision of the future, presented in a passage from a published conversation, is ...

New research in Advanced Science reveals that the secreted protein LRG1 drives pathological angiogenesis in bladder cancer by ...

First clinical data for CPV-104 in patients, including interim safety, tolerability and pharmacokinetics, accepted as a late-breaking ...

"Why does aging happen in the first place?"A hypothesis is presented that death and aging are advantageous traits selected during the process of evolution.This book organizes life science from the ...

A new review in BMC Medicine argues that disrupted lipid homeostasis is an early, measurable, and modifiable driver of brain aging and Alzheimer's disease, opening a window for ...

Award to Dr. Walter Swardfager, from Sunnybrook Research Institute, will support a proof-of-mechanism clinical trial ...

Eli Lilly owned a pre-IPO stake in TRex Bio that was the equivalent of 23.9 percent of the biotech’s outstanding stock; that stake was set to decline to 16.8 percent of TRex Bio’s outstanding shares ...

A recent study published in Nature Neuroscience has revealed a vascular platform located in the dura mater of the meninges ...

DeJoria most recently reported beneficial ownership of approximately 3.55 million shares, representing approximately 5.0% of Telomir’s outstanding common stock. His additional $1.0 million investment ...

A new review examines adipocyte ferroptosis, the breakdown of fat cells due to oxidation from intracellular iron, as an ...

Telomir Pharmaceuticals (NASDAQ: TELO) announced an approximately $5.6 million private investment in public equity (“PIPE”) financing through the issuance of 4,843,300 common shares at $1.16 per share ...